A colleague of mine spent the better part of a year designing a value-based insurance plan that would have made any actuary weep with joy. Zero-dollar copays for insulin and ACE inhibitors. Higher cost-sharing for low-value imaging. A formulary that actually rewarded people for filling evidence-based prescriptions. The CFO loved it. The clinical case was unassailable. Then came the first test file with the benefits administration platform, and the whole thing fell apart at the seams.
The enrollment system couldn’t read the plan mapping. The eligibility feed threw a cryptic error code no one on the implementation call had ever seen. The member-facing shopping tool, built for flat copays and simple deductibles, slathered a generic cost-share layer on top of the carefully zeroed-out preventive tier. A design that was supposed to remove barriers for the sickest members instead created a wave of confused calls to HR and a very angry email chain with the PBM. That’s the moment I realized: in this industry, we’ve spent years perfecting the what of V-BID and almost no time on the how.
The 834 File Doesn’t Care About Your Clinical Evidence
Value-based insurance design makes intuitive sense: align what people pay with the clinical value of the care they’re getting. No one wants to explain to an employee why their heart failure medication costs the same out-of-pocket as a drug they saw in a commercial during a football game. But that elegant logic has to squeeze itself into some of the most inflexible data pipes in American business. The ANSI 834 file, that workhorse of enrollment feeds, was built in an era when “plan design” meant picking a deductible, an out-of-pocket max, and maybe three tiers of copays. It doesn’t have a field for “this service is high-value for members with condition X.” It doesn’t carry clinical nuance. It carries coverage levels and network IDs, and it expects the world to be that simple.
So when an employer wants to carve out certain drugs or visits based on diagnosis codes, suddenly you’re not just sending an 834. You’re building a parallel infrastructure of real-time pharmacy adjudication rules, prior authorization logic that runs silently in the background, and accumulator engines that need to track whether a particular claim should credit toward the deductible or bypass it entirely. If those systems aren’t perfectly synchronized-and they almost never are at launch-members get billed incorrectly. The plan doesn’t look value-based from their side of the equation; it looks broken.
The HSA Tangle Most Teams Overlook
If you really want to see a systems headache, try layering V-BID onto an HSA-qualified HDHP. The IRS tossed employers a lifeline in 2019 by expanding the preventive care safe harbor to include 14 services for people with certain chronic conditions. Diabetics could finally get insulin and A1c tests covered pre-deductible without killing their HSA eligibility. That’s a genuine win, but the administrative lift is enormous. First, your claims system has to identify who qualifies based on a diagnosis. Then it has to apply that pre-deductible benefit only to the listed items, while keeping everything else behind the deductible wall.
Many mid-market TPAs run on plan parameter setups that are, shall we say, rigid. They can’t dynamically segment a population by condition without manual overrides. So the employer either over-applies the exemption to people who don’t qualify-a compliance flag-or under-applies it, leaving the very members the design was meant to help still facing full cost-sharing. I’ve seen teams resort to bolting on a separate disease management program with its own eligibility file, which fractures the enrollment experience and creates one more brittle data feed to babysit. It’s a Rube Goldberg machine where a clean, simple benefit should be.
Your RFP Never Asked the Right Questions
I’ve sat through enough vendor demos to know the pattern. The benefits administration RFP grills the vendor on open enrollment functionality, EDI turnaround times, and life-event processing. It asks about their call center hours and their mobile app rating. It almost never asks the questions that actually determine whether a V-BID design will survive implementation:
- Can the enrollment platform display plan tiers that shift based on clinical pathways, not just network or metal level?
- Will the PBM integration consume the chronic-condition exemption list automatically, or will someone on our team be reconciling spreadsheets every month?
- How does the accumulator engine handle claims that straddle the boundary between high-value and standard cost-sharing?
- Can the decision-support tool incorporate lawful health risk data to show a member with diabetes what their actual out-of-pocket costs will look like under this plan?
When those questions go unasked, the implementation team inherits a plan design that requires custom development no one scoped. The vendor’s sales engineer didn’t flag the complexity because, frankly, they’d never seen a build request quite like it. So the employer signs the contract, and three months before open enrollment, they discover the beautiful design needs 18 weeks of technical work.
The Compliance Shadow You Can’t Ignore
Here’s where the systems trap gets a legal edge. Under ERISA, plan fiduciaries have to act prudently and in participants’ interest. A V-BID design that steers people toward high-value care and away from wasteful services is arguably the most fiduciary-minded thing you can do-provided the machinery actually works. If the claims system can’t reliably distinguish between high-value and low-value at the line-item level, members are going to overpay for things that should have been covered at a lower cost-share. That means appeals. That means fiduciary breach risk if the pattern is bad enough. Your operational integrity isn’t just a nice-to-have; it’s part of your legal exposure.
Then there’s the nondiscrimination piece under Section 105(h) of the tax code. V-BID inherently creates different benefit levels based on health status. The IRS safe harbor gives you some protection for the listed preventive services, but any design element that goes further demands careful documentation. If your ben admin system can’t produce clean reports showing who received what benefit and under which clinical criteria, you’re flying blind. And if you can’t document it, you can’t defend it.
How to Build a System That Actually Delivers
The good news is that the market is catching up. Some PBMs now handle indication-based formularies without a dozen workarounds. A few cloud-native ben admin platforms are starting to embed condition-specific plan designs natively. But it’s not turnkey, and it won’t be for a while. Here’s what I tell benefits leaders who want to escape the trap:
- Start with a technical audit before you touch clinical design. Map every data handshake you’ll need: eligibility file to carrier, carrier to PBM, accumulator to member portal, wellness platform to enrollment tool. Circle any spot where a human being might have to manually adjust something. Price that operational cost. You’ll be surprised how expensive a “small” manual reconciliation becomes at scale.
- Make the vendor build a mock plan in a test environment. Don’t just take the implementation team’s word for it. Hand them a realistic scenario-say, a diabetic member filling insulin and getting a retinopathy screening-and ask them to run it through the claims engine. Watch what breaks. It will break somewhere.
- Layer decision support responsibly. If you’ve captured health risk data through a wellness program, work with legal to integrate de-identified patterns into your enrollment tool. Let employees see personalized cost estimates that reflect the V-BID tiers, but stay far clear of HIPAA and GINA tripwires.
- Turn member grievances into system intelligence. Every time someone disputes a charge tied to the V-BID logic, treat it as a signal. Is it an accumulator misalignment? A PBM configuration error? A communication gap where the SPD promised one thing and the portal showed another? Feed that data back to your vendors quarterly and write it into your SLAs.
Value-based insurance design isn’t going away, and it shouldn’t. Done well, it’s the difference between a plan that just pays claims and one that actively keeps people healthier. But we have to stop pretending that a white paper and a clever copay structure are enough. The architecture that turns policy into payment is what actually touches the member. Until we obsess over that architecture with the same energy we pour into clinical evidence, we’ll keep designing flawless plans that fail the moment they meet the real world.